EcoDrugPlus

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSUAMG00000009743
Gene Symbol: GSK3B
2 Cross references
241 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSUAMG00000009351
Gene Symbol: GHRHR
2 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSUAMG00000018556
Gene Symbol: GHSR
2 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSUAMG00000000879
Gene Symbol: GUCY1A1
2 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSUAMG00000021756
Gene Symbol: GUCY1B1
2 Cross references
209 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSUAMG00000018640
Gene Symbol: HSP90AA1
2 Cross references
199 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSUAMG00000016661
Gene Symbol: HSP90AB1
2 Cross references
203 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSUAMG00000021252
Gene Symbol: HRH1
2 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSUAMG00000012361
Gene Symbol: HRH2
2 Cross references
249 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSUAMG00000025262
Gene Symbol: HRH3
2 Cross references
117 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSUAMG00000014267
Gene Symbol: HDAC1
2 Cross references
284 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSUAMG00000013424
Gene Symbol: HDAC10
2 Cross references
181 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).